Imaging stem cell implants in neurodegenerative disease

描述(由申请人提供)： 尽管付出了相当大的努力，但仍然没有可靠的方法来防止或挽救多巴胺(DA)神经元在衰老或帕金森病(PD)过程中发生的进行性退化。由于临床诊断几乎总是在绝大多数DA神经元被破坏后进行，研究人员继续努力开发用能够发挥多巴胺功能的移植细胞来取代丢失的组织的方法。我们的目标是L研究移植到帕金森病大鼠体内的工程干祖细胞或胎儿DA神经元的纯化群体。这些方法的一个主要局限性是，如果没有高度侵入性的组织活检，就无法监测移植细胞的进展，这总是会导致动物死亡。如果能够对每种动物进行非侵入性和重复的研究，这些研究所需的大量动物可以显著减少(随之而来的是成本的降低)。此外，在体外的大鼠模型中对DA神经元再生的测量对人类是不可翻译的。使用PET和SPECT对帕金森病和其他神经退行性疾病的动物模型进行分子成像，可以研究这种疾病的体内神经化学基础。在这项建议中，我们的目标是在干细胞植入后的一段较长时间内，对同一动物进行纵向研究，对体内的多巴胺能神经元进行定量成像。我们的目标是使用超高分辨率的PET和SPECT来验证大鼠的多巴胺能功能的定量模型。[18F]DOPA成像将与PET一起用于监测纹状体多巴脱羧酶活性，而[99mTC]TRODAT-1和SPECT将直接用于测量多巴胺转运体(DAT)的可用性。这些方法将根据已建立的尸检方法进行验证，如GFP报告基因表达和免疫细胞化学。干细胞植入后对大鼠的纵向成像研究将使我们能够看到DA神经元在更长一段时间内的再生。一旦成像技术得到充分验证，它们将被应用于各种干细胞植入模型，并与行为研究相关联。这种非侵入性的方法将使细胞类型和生长因子的最佳组合得以建立，而不会牺牲动物。这项研究的最终目标是开发能够在体内监测帕金森氏症和其他神经退行性疾病中DA神经元替代治疗的方法。这将为帕金森病的动物模型提供重要信息，使我们能够纵向跟踪DA神经元的再生，最重要的是，将可移植到使用类似技术的临床人类研究中。

DESCRIPTION (provided by applicant): Despite considerable effort, there is still no reliable way to either prevent or rescue dopamine (DA) neurons from the progressive degeneration that occurs during aging or in Parkinson's Disease (PD). Since clinical diagnosis almost always occurs after the vast majority of DA neurons have been destroyed, researchers continue to work to develop ways in which to replace lost tissue with transplanted cells capable of dopaminergic function. Our goal is l to study purified populations of engineered stem, progenitor or fetal DA neurons after transplantation into the Parkinsonian rat. A major limitation of these approaches is the inability to monitor the progression, if any, of the grafted cells without highly invasive tissue biopsy, which invariably results in the death of the animal. The vast numbers of animals required for these studies could be reduced significantly (with the concomitant reduction in costs) if each animal could be studied non-invasively and repeatedly. In addition, measurements made of the DA neuronal regeneration in a rat model ex vivo are not translatable to humans. Molecular imaging, using PET and SPECT, of animal models of PD, and other neurodegenerative diseases, enables the study of the in vivo neurochemical basis of the disorder. In this proposal we aim to perform quantitative imaging of dopaminergic neurons in vivo in longitudinal studies of the same animals over an extended period of time after stem cell implantation. We aim to validate quantitative models of dopaminergic function in rats, using ultra-high resolution] PET and SPECT. [18F]DOPA imaging will be used with PET to monitor striatal dopa decarboxylase activity, while [99mTc]TRODAT-1 and SPECT will be used to measure dopamine transporter (DAT) availability directly. These will be validated against established post mortem methods, such as GFP reporter gene expression and immunocytochemistry. Longitudinal imaging studies of rats, following stem cell implantation, will enable the visualization of the regeneration of DA neurons over an extended period of time. Once the imaging techniques have been fully validated, they will be applied to a variety of stem cell implant models, and correlated with behavioral studies. This non-invasive approach will enable the best combination of cell types and growth factors to be established without sacrificing the animals. The ultimate goal of this study is to develop methods which will enable the monitoring in vivo of DA neuron replacement treatments in Parkinson's and other neurodegenerative diseases. This will provide vital information in the animal model of PD, allow us to longitudinally follow DA neuron regeneration, and, most importantly, will be translatable to clinical human studies using similar techniques.